Sessa Capital (Master), L.P.'s Net Worth
$266 Million
Who is Sessa Capital (Master), L.P.?
Sessa Capital (Master), L.P. has an estimated net worth of $266 Million. This is based on reported shares across multiple companies, which include COMPX INTERNATIONAL INC, Garrett Motion Inc., Provention Bio, Inc., and SAB Biotherapeutics, Inc..
SEC CIK
Sessa Capital (Master), L.P.'s CIK is 0001618360
Past Insider Trading and Trends
2023 was Sessa Capital (Master), L.P.'s most active year for acquiring shares with 11 total transactions. Sessa Capital (Master), L.P.'s most active month to acquire stocks was the month of October. 2023 was Sessa Capital (Master), L.P.'s most active year for disposing of shares, totalling 12 transactions. Sessa Capital (Master), L.P.'s most active month to dispose stocks was the month of March. 2023 saw Sessa Capital (Master), L.P. paying a total of $124,461,138.00 for 31,903,291 shares, this is the most they've acquired in one year. In 2023 Sessa Capital (Master), L.P. cashed out on 49,935,842 shares for a total of $112,743,151.68, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
COMPX INTERNATIONAL INC (CIX) Snapshot price: $24.12
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Garrett Motion Inc. (GTX) Snapshot price: $8.405
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -39.63% | -10.00M |
$9.00 | -$90,000,000.00 | 15.24M |
Mar 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +7.37% | 1.73M |
—
|
—
| 25.24M |
Jun 13
| |||
Form 4
| +240.04% | 16.59M |
—
|
—
| 23.5M |
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -100.00% | -6.91M |
—
|
—
|
0
|
Apr 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Provention Bio, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -15.57M |
—
|
—
|
0
|
Apr 27
| |||
Form 4
| -100.00% | -426.93K |
—
|
—
|
0
|
Apr 20 - Apr 21
| |||
Form 4
| +75.33% | 6.69M |
$15.16 | -$13.68 | 15.57M |
Apr 14
| |||
Form 4
| -25.70% | -3.22M |
—
|
—
| 9.31M |
Mar 31 - Apr 4
| |||
Form 4
| -20.16% | -3.00M |
$9.40 | -$28,200,000.00 | 11.88M |
Jan 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SAB Biotherapeutics, Inc. (SABS) Snapshot price: $5.58
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 4.58M |
—
|
—
| 4.58M |
Nov 24
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Nov 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 10 - Nov 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||